• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Astrazeneca’s Biologics Saphnelo Receives Approval in US

    FDA

    AstraZeneca`s Kavigale Receives Approval in Canada

    HEALTH CANADA

    AstraZeneca`s Biologic Imfinzi Receives Suppl Approval in US

    FDA

    AstraZeneca`s Byetta Receives Approval in US

    FDA

    AstraZeneca`s Biologic Beyfortus (Nirsevimab) Receives Suppl Approvals in US

    FDA

    AstraZeneca`s Biologic Imfinzi (Durvalumab) Receives Suppl Approvals in US

    FDA

    AstraZeneca`s Biologic Imjudon (Tremelimumab) Receives Suppl Approvals in US

    FDA

    AstraZeneca`s Truqap (capivasertib) Receives Approval In Europe

    EMA

    Astrazeneca Uk Biologic Durvalumab Receives Suppl Approval in US

    FDA

    AstraZeneca`s Fluenz (influenza vaccine) Receives Approval in Europe

    EMA

    AstraZeneca UK Imfinzi (Durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Beyfortus (nirsevimab-alip) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imjudo (tremelimumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imfinzi (durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Evusheld (tixagevimab, cilgavimab) Receives Approval in Europe

    EMA

    AstraZeneca`s Tezspire (tezepelumab) Receives Approval in Europe

    EMA

    AstraZeneca`s Biologic Beyfortus (nirsevimab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Beyfortus (nirsevimab) Approved In Europe

    EMA

    AZ`s Beyfortus (Nirsevimab) Receives Approval in Europe

    EMA

    AstraZeneca`s Biologic Imfinzi (Durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imjudo (Tremelimumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Tremelimumab Receives Approval in Europe

    EMA

    AstraZeneca`s Beyfortus(nirsevimab) Receives Approval in Europe

    EMA

    AstraZeneca`s Imjudo (Tremelimumab) Receives Approval in Europe

    EMA

    AstraZeneca`s Imjudo (Tremelimumab) Approved In Europe

    EMA

    AstraZeneca`s Biologic Tezspire (Tezepelumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Evusheld (tixagevimab / cilgavimab) Receives Approval in the Europe

    EMA

    AstraZeneca`s Beyfortus (nirsevimab) Receives Approval in Europe

    EMA

    AstraZeneca`s Biologic Imjudo (Tremelimumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imfinzi (Durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imjudo (Tremelimumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imjudo (Tremelimumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Tezspire (tezepelumab) Receives Approval in Europe

    EMA

    AstraZeneca`s Biologic Imfinzi (Durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca`s Biologic Imfinzi (Durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca UK Imfinzi(Durvalumab) Receives Approval in the U.S.

    FDA

    AstraZeneca AB Evusheld (tixagevimab/cilgavimab)Receives Approval in Europe

    EMA

    Astrazeneca`s Biologic Saphnelo (Aniforlumab) Receives Approval in Europe

    EMA

    Astrazeneca`s Biologic Riltrava Aerosphere Receives Approval in Europe

    EMA

    AstraZeneca`s Biologic Tezspire (Tezepelumab-Ekko) Receives Approval in the U.S.

    FDA

    Astrazeneca`s Biological Durvalumab Receives Approval in US

    FDA

    AZ`s Uk Imfinzi (Durvalumab) Receives Supplemental Approval In US

    FDA

    AZ`s Luxomiti (Moxetumomab pasudotox tdfk) Receives Supp. Approval in US

    FDA

    AZ`s Lumoxiti (Moxetumomab Pasudotox TDFK) Receives Supplemental Approval in US

    FDA

    AZ`s Imfinzi (Durvalumab) Receives Supplemental Approval in US

    FDA

    AstraZeneca`s Imfinzi (Durvalumab) Receives Supplemental Approval in US

    FDA

    AstraZeneca AB`s Fasenra (Benralizumab) Receives Supplemental Approval in US

    FDA

    AstraZeneca AB`s Bevespi Aerosphere (glycopyrronium / formoterol fumarate dihydrate) Receives Approval in Europe

    EMA

    Astrazeneca`s Lumoxiti (Moxetumomab Pasudotox-Tdfk) Receives Approval in US

    FDA

    Ofloxacin - List of nationally authorised medicinal products

    EMA

    AstraZeneca`s Imfinzi (durvalumab) Receives Approval in Europe

    EMA

    Astrazeneca AB`s Lumoxiti (Moxetumomab Pasudotox-tdfk) Receives Supplemental Approval in US

    FDA

    AstraZeneca`s Lokelma (Sodium zirconium cyclosilicate) Receives Approval In Europe

    EMA

    AstraZeneca Fasenra (benralizumab) Receives Approval In Europe

    EMA

    Medimmune’s Synagis Palivizumab Receives Supplemental Approval In US

    Astrazeneca Uk Ltd Imfinzi (Durvalumab) Receives Supplemental Approval In US

    FDA

    ANVISA Has Approved The Registration Of Lynparza® (Olaparib)

    ANVISA

    Anvisa Approved The Registration Of The New Drug Tagrisso

    ANVISA

    AstraZeneca AB`s Qtern (saxagliptin / dapagliflozin propanediol monohydrate) receive market authorisation in EU for Diabetes Mellitus, Type 2

    EMA

    AstraZeneca`s Zavicefta receives market authorisation in EU for Infections

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.